secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001193125-26-202614
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health receives Nasdaq delisting notice for insufficient publicly held shares after reverse split
--------------------------------------------------------------------------------

- Post 1-for-35 reverse stock split on April 30, 2026, publicly held shares are ~401,226, below 500,000 minimum.
- Nasdaq Staff notified company on May 1, 2026 of additional deficiency under Listing Rule 5550(a)(4).
- Company must present views to Nasdaq Hearings Panel by May 8, 2026; failure may lead to delisting.
- Company remains non-compliant with both minimum bid price and public shares requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526202614/0001193125-26-202614-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526202614/d46623d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-202614

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer